Investigation of Placentas of Preeclamptic Patients with Very Premature Membrane Rupture
Abstract
Purpose: In this study, placental histological differences between the control group and the PROM+preeclampsia group were evaluated.
Materials and Methods: In our study, placentas were obtained from a total of 90 pregnant patients (regardless of age), including 45 control and 45 PROM+Preeclampsia pregnant patients, by obtaining informed consent form.
Results: In the control group, placental structures appeared normal with regular chorionic villi, properly organized trophoblast layers, minimal syncytial nodes, and limited fibrin accumulation. Villous capillary endothelial cells were thin and elongated, while stromal cells were well-placed without signs of bleeding or inflammation. In the PROM+preeclampsia group, villous degeneration, trophoblastic apoptosis, vascular congestion, endothelial hyperplasia, and increased fibrin deposition were observed. The intervillous area showed extensive hemorrhage and immune cell infiltration, with numerous Hoffbauer cells in the villous stroma and marked decidual cell degeneration near the maternal plate.
Conclusion: In our study, placental histopathological changes observed in the PROM+preeclampsia group show that this condition may seriously affect the placental structure.
Keywords: placenta, PROM, histopathology, preeclampsia
Keywords:
placenta, PROM, histopathology, preeclampsiaDOI
https://doi.org/10.22270/jddt.v15i2.7018References
1. Jung A, Challoumas D, Pagels L, Armijo-Olivo S, Braun T, Luedtke K. Guidelines for the development and validation of patient-reported outcome measures: a scoping review. BMJ Evid Based Med. 2024 Nov 22;29(6):363-373. https://doi.org/10.1136/bmjebm-2023-112681 PMid:38782559
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-99. https://doi.org/10.1016/S0140-6736(05)17987-2 PMid:15733721
3. Gokalp-Ozkorkmaz E, Asir F, Basaran SO, Agacayak E, Sahin F, Kaya S, Erdogan G, Deveci E. Examination of Bcl-2 and Bax Protein Levels for Determining the Apoptotic Changes in Placentas with Gestational Diabetes and Preeclampsia. Proceedings. 2018; 2(25):1548. https://doi.org/10.3390/proceedings2251548
4. Sutapa A, Gagandeep KW. Prevalence and risk factors for symptoms suggestive of pre-eclampsia in Indian women. J Womens Health. 2014;3:1-9.
5. Jung A, Challoumas D, Pagels L, Armijo-Olivo S, Braun T, Luedtke K. Guidelines for the development and validation of patient-reported outcome measures: a scoping review. BMJ Evid Based Med. 2024 Nov 22;29(6):363-373 https://doi.org/10.1136/bmjebm-2023-112681 PMid:38782559
6. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-7. https://doi.org/10.1053/j.semperi.2009.02.010 PMid:19464502
7. Aşır F, Oğlak SC, Ağaçayak E, Alabalık U. Homeobox A Cluster 7 (HOXA7) protein expression increased in the placentas of patients with preterm delivery. Perinatal Journal 2023;31(3):213-218
8. Mostello D, Catlin TK, Roman L, Holcomb WL, Jr, Leet T. Preeclampsia in the parous woman- who is at risk. Am J Obstet Gynecol. 2002;187:425-9. https://doi.org/10.1067/mob.2002.123608 PMid:12193937
9. Gandhi M, Shah F, Panchal C. Obstetric outcomes in premature rupture of the membrane. Int J Gynecol Obstet. 2012;16:1-5. https://doi.org/10.5580/2ed6
10. Aydeniz Acar, G. E., Sevinç Akdeniz, A., Türe, Z., Aşır, A., Acar, M., Aşır, F., ... KORAK, T.(2024). HOXA1 expression in placentas of woman with fetal growth restriction. Perinatal Journal , vol.32, no.2, 166-172.
11. Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring. J Clin Med. 2019 Oct 4;8(10):1625. https://doi.org/10.3390/jcm8101625 PMid:31590294 PMCid:PMC6832549
12. Ali M, Ahmed M, Memon M, Chandio F, Shaikh Q, Parveen A, Phull AR. Preeclampsia: A comprehensive review. Clin Chim Acta. 2024 Sep 15;563:119922. https://doi.org/10.1016/j.cca.2024.119922 PMid:39142550
13. Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Oct 6;76(14):1690-1702. https://doi.org/10.1016/j.jacc.2020.08.014 PMid:33004135
14. Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, Whitehead C, Hyett J, da Silva Costa F, Nicolaides K, Menkhorst E. Pre-eclampsia. Nat Rev Dis Primers. 2023 Feb 16;9(1):8. https://doi.org/10.1038/s41572-023-00417-6 PMid:36797292
15. Gelkopf M, Mazor Y, Roe D. A systematic review of patient-reported outcome measurement (PROM) and provider assessment in mental health: goals, implementation, setting, measurement characteristics and barriers. Int J Qual Health Care. 2021 Mar 5;34(Suppl 1):ii13-ii27. doi: 10.1093/intqhc/mzz133. Erratum in: Int J Qual Health Care. 2022 Mar 28;34(Suppl 1):ii112. https://doi.org/10.1093/intqhc/mzz133 PMid:32159763
16. Fuat Zaman, Fırat Aşır, Işılay Sezen Ermiş, Mehmet Cudi Tuncer, Engin Deveci, Süleyman Cemil Oğlak. Immunohistochemical Analysis of Vimentin and Zonula Occludens-1 in Placentas of Patients with PPROM. Clin. Exp. Obstet. Gynecol. 2024, 51(1), 18. https://doi.org/10.31083/j.ceog5101018
17. Sokas C, Hu F, Edelen M, Sisodia R, Pusic A, Cooper Z. A Review of PROM Implementation in Surgical Practice. Ann Surg. 2022 Jan 1;275(1):85-90. https://doi.org/10.1097/SLA.0000000000005029 PMid:34183512
18. Churruca K, Pomare C, Ellis LA, Long JC, Henderson SB, Murphy LED, Leahy CJ, Braithwaite J. Patient-reported outcome measures (PROMs): A review of generic and condition-specific measures and a discussion of trends and issues. Health Expect. 2021 Aug;24(4):1015-1024. https://doi.org/10.1111/hex.13254 PMid:33949755 PMCid:PMC8369118
Published
Abstract Display: 67 
PDF Downloads: 51 PDF Downloads: 2 How to Cite
Issue
Section
Copyright (c) 2025 Serhat Ege , Murat Akkuş , Fırat Aşır , Medine Arslan Alcan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.